Description
Overview
Tirzepatide is a synthetic peptide that activates two incretin receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It was the first dual incretin agonist of its kind, and it has become a key reference compound for research into how combined GIP and GLP-1 signaling compares with GLP-1 signaling alone.
Peptide Sciences Bio supplies tirzepatide 5mg as a high-purity lyophilized powder for in-vitro and preclinical laboratory investigation. Every batch is supported by independent analytical testing and a published Certificate of Analysis.
Product Specifications
| Product | Tirzepatide |
|---|---|
| Quantity | 5mg per vial |
| Class | Dual GIP / GLP-1 receptor agonist |
| Length | 39 amino acids, with C20 fatty diacid side chain |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.45 g/mol |
| CAS number | 2023788-19-2 |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC) |
| Documentation | Batch-specific Certificate of Analysis |
Background: The Incretin System
Incretins are gut hormones released after nutrient intake. The two best characterized are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both act on pancreatic beta cells to support glucose-dependent insulin secretion, and their receptors are also found in the brain, gastrointestinal tract and adipose tissue. Native GLP-1 and GIP are broken down within minutes by the enzyme DPP-4, so research compounds in this class are engineered for much longer stability, typically through amino acid substitutions and fatty acid chains that bind to serum albumin.
Structure & Design
Tirzepatide’s backbone is based on the native GIP sequence, engineered to also activate the GLP-1 receptor. It includes two α-aminoisobutyric acid (Aib) residues that protect against DPP-4 degradation, and a C20 fatty diacid chain attached to a lysine residue, which binds serum albumin and extends its duration of action to roughly a week in pharmacokinetic studies.
Receptor pharmacology studies describe tirzepatide as “imbalanced”: it acts at the GIP receptor with potency similar to native GIP, while showing lower potency and a biased signaling profile at the GLP-1 receptor.
Mechanisms Studied
- GIP receptor activation: research on GIP signaling in pancreatic, adipose and central nervous system tissue.
- GLP-1 receptor activation: cAMP signaling with reduced beta-arrestin recruitment, studied as an example of biased agonism.
- Glucose-dependent insulin secretion: combined incretin effects on pancreatic beta cells.
- Adipose tissue biology: GIP receptor effects on lipid handling in adipocytes.
- Central energy balance: hypothalamic and brainstem signaling in appetite regulation models.
Areas of Study
- Glucose metabolism and insulin sensitivity research
- Energy homeostasis and appetite regulation models
- Adipose tissue and lipid metabolism research
- Hepatic steatosis models
- Dual versus single incretin agonist comparisons
These findings come from laboratory, animal and clinical research on tirzepatide as a pharmaceutical ingredient. They do not apply to this research-grade material, which is not an approved drug product and is not intended for human use.
Available Sizes
Peptide Sciences Bio offers tirzepatide in 5mg, 10mg and 15mg vials. The compound is identical across sizes; the choice depends on the scale and duration of the planned research.
Related Research Peptides
- Tirzepatide 10mg
- Tirzepatide 15mg
- Semaglutide Peptide 3mg
- Retatrutide 6mg
- Cagrilintide Peptide 10mg
- MOTS-c Peptide 5mg
Quality & Testing
Every batch of tirzepatide is independently tested for identity and purity before release. Testing includes high-performance liquid chromatography (HPLC) to confirm purity and mass spectrometry (MS) to confirm molecular identity. The batch-specific Certificate of Analysis is available on this page and in our COA library, so researchers can verify the exact material they receive.
Storage & Handling
- Store lyophilized tirzepatide at −20°C, protected from light and moisture.
- Short-term storage at 2–8°C is acceptable for lyophilized material.
- Allow the vial to reach room temperature before opening to limit condensation.
- Handle using standard laboratory practices and appropriate protective equipment.
For laboratory solution preparation, see our Peptide Reconstitution Guide.
Frequently Asked Questions
What is tirzepatide?
Tirzepatide is a synthetic peptide that activates both the GIP and GLP-1 receptors. It is studied in research on incretin signaling, glucose regulation and energy homeostasis.
How does tirzepatide differ from semaglutide and retatrutide?
Semaglutide activates the GLP-1 receptor only. Tirzepatide activates the GIP and GLP-1 receptors. Retatrutide adds a third target, the glucagon receptor.
Is this the same as the prescription medicine?
No. tirzepatide is the active ingredient in FDA-approved prescription medicines, but this product is not one of them. Peptide Sciences Bio’s tirzepatide is a research-grade material that is not approved for human or veterinary use and is sold strictly for laboratory research.
How should tirzepatide be stored?
Lyophilized tirzepatide should be stored at −20°C, away from light and moisture. Short-term storage at 2–8°C is acceptable.
What does the Certificate of Analysis include?
Each COA reports the batch number, HPLC purity results and mass spectrometry confirmation of molecular identity for that specific batch.
Research Use Only
This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis, treatment or prevention of any condition. Purchase is restricted to buyers who agree to our Terms of Sale.
Additional information
| Product Form | Lyophilized Powder (Vial) |
|---|
Tirzepatide 5mg
$125.00
Tirzepatide 5mg is a 39-amino-acid dual GIP and GLP-1 receptor agonist peptide, modified with a C20 fatty diacid chain for albumin binding. It is studied in preclinical and clinical research on incretin signaling, glucose regulation and energy homeostasis. Supplied as a lyophilized powder at ≥99% purity (HPLC), with batch-specific COA available. For laboratory research use only.
Worldwide tracked delivery. Dispatched within 24 hours of order confirmation.
Not satisfied? Return any item within 10 days for a full refund, no questions asked.



